|Bid||0.00 x 0|
|Ask||1,560.00 x 0|
|Day's range||905.00 - 955.00|
|52-week range||905.00 - 1,678.00|
|Beta (5Y monthly)||0.78|
|PE ratio (TTM)||41.13|
|Earnings date||13 Apr 2022 - 18 Apr 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1,810.86|
With UK stocks on the rise in 2022, Zaven Boyrazian shares his top pick from his own portfolio that could deliver triple-digit returns. The post 1 UK stock I’d buy in 2022 to try to double my money appeared first on The Motley Fool UK.
John Dawson to retire from Oxford Biomedica Oxford, UK – 17 January 2022: Oxford Biomedica plc (LSE:OXB) (“Oxford Biomedica” or “the Group” or “the Company”) a leading gene and cell therapy company, today announces that, after more than 13 years of service, John Dawson, Chief Executive Officer, has signalled to the Board his intention to retire from the Company. Accordingly, the Board has initiated a formal search for a successor. Dr. Roch Doliveux, Chairman of Oxford Biomedica, commented: “John
Every investor in Oxford Biomedica plc ( LON:OXB ) should be aware of the most powerful shareholder groups. Insiders...